Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections

E. A. Piercy, D. Barbaro, J. P. Luby, P. A. Mackowiak

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Thirty-seven patients with meticillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55% of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.

Original languageEnglish (US)
Pages (from-to)128-130
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume33
Issue number1
StatePublished - 1989

Fingerprint

Methicillin-Resistant Staphylococcus aureus
Ciprofloxacin
Infection
Methicillin
Staphylococcus aureus
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections. / Piercy, E. A.; Barbaro, D.; Luby, J. P.; Mackowiak, P. A.

In: Antimicrobial Agents and Chemotherapy, Vol. 33, No. 1, 1989, p. 128-130.

Research output: Contribution to journalArticle

Piercy, E. A. ; Barbaro, D. ; Luby, J. P. ; Mackowiak, P. A. / Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections. In: Antimicrobial Agents and Chemotherapy. 1989 ; Vol. 33, No. 1. pp. 128-130.
@article{98d883277c3f42479d59acac06d78c69,
title = "Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections",
abstract = "Thirty-seven patients with meticillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91{\%} of the patients, and bacteriologic cure occurred in 60{\%}. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55{\%} of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.",
author = "Piercy, {E. A.} and D. Barbaro and Luby, {J. P.} and Mackowiak, {P. A.}",
year = "1989",
language = "English (US)",
volume = "33",
pages = "128--130",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections

AU - Piercy, E. A.

AU - Barbaro, D.

AU - Luby, J. P.

AU - Mackowiak, P. A.

PY - 1989

Y1 - 1989

N2 - Thirty-seven patients with meticillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55% of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.

AB - Thirty-seven patients with meticillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55% of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.

UR - http://www.scopus.com/inward/record.url?scp=0024558632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024558632&partnerID=8YFLogxK

M3 - Article

C2 - 2712546

AN - SCOPUS:0024558632

VL - 33

SP - 128

EP - 130

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 1

ER -